EP

Epi Biotech Co., Ltd.

Develops hair loss therapies and provides preclinical CRO services.

446440 | KO

Overview

Corporate Details

ISIN(s):
KR7446440000
LEI:
Country:
South Korea
Address:
인천광역시 연수구 송도과학로 32 엠동 1903호(송도동, 송도테크노파크아이티센터), 인천광역시

Description

Epi Biotech Co., Ltd. is a biopharmaceutical company focused on the research and development of treatments for hair loss. The company utilizes a large genomic database and AI-driven drug discovery platforms to advance its pipeline, which includes cell and antibody therapeutics for hair restoration. In addition to its primary focus, Epi Biotech conducts R&D in skin regeneration. The company also provides specialized preclinical Contract Research Organization (CRO) services, offering expertise in hair loss research and efficacy evaluation.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-31 00:00
임시주주총회결과
Korean 8.2 KB
2025-07-31 00:00
주식매수선택권부여에관한신고
Korean 20.6 KB
2025-07-16 00:00
[기재정정]주주총회소집결의
Korean 12.9 KB
2025-07-16 00:00
주주총회소집공고
Korean 71.6 KB
2025-06-24 00:00
주주총회소집결의
Korean 8.1 KB
2025-06-24 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2025-05-12 00:00
주식등의대량보유상황보고서(약식)
Korean 168.9 KB
2025-04-24 00:00
증권발행결과(자율공시)
Korean 5.1 KB
2025-04-16 00:00
주요사항보고서(유상증자결정)
Korean 51.4 KB
2025-03-26 00:00
정기주주총회결과
Korean 17.2 KB
2025-03-26 00:00
주식등의대량보유상황보고서(일반)
Korean 91.4 KB
2025-03-19 00:00
증권발행결과(자율공시)
Korean 5.1 KB
2025-03-19 00:00
증권발행결과(자율공시) (제3자배정 유상증자)
Korean 5.1 KB
2025-03-18 00:00
감사보고서제출
Korean 9.8 KB
2025-03-18 00:00
사업보고서 (2024.12)
Korean 748.3 KB

Automate Your Workflow. Get a real-time feed of all Epi Biotech Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Epi Biotech Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Epi Biotech Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Nicox S.A. Logo
Ophthalmology company developing therapies based on a nitric oxide-donating platform.
France
COX
NLS Pharmaceutics Ltd. Logo
Clinical-stage biopharma firm developing therapies for rare and complex CNS disorders.
United States of America
NLSP
NovoCure Ltd Logo
Develops a non-invasive cancer therapy using electric fields to disrupt solid tumors.
United States of America
NVCR
NUFORMIX PLC Logo
Pharmaceutical developer using cocrystal technology to repurpose drugs for fibrosis.
United Kingdom
NFX
Nurix Therapeutics, Inc. Logo
Clinical-stage biopharma developing protein degradation therapies for various diseases.
United States of America
NRIX
OLIPASS CORPORATION Logo
An R&D company developing RNA therapeutics using its proprietary OPNA platform.
South Korea
244460
A technology platform for therapeutic antibody discovery using transgenic animals.
United States of America
OABIW
ONCIMMUNE HOLDINGS PLC Logo
Immunodiagnostics company specializing in antibody and autoantibody biomarker signatures.
United Kingdom
ONC
Oncocross Co.,Ltd. Logo
An AI biotechnology firm that develops drugs by predicting drug-disease interactions.
South Korea
382150
ONCODESIGN Logo
Develops therapeutic and diagnostic solutions for resistant and metastatic cancers.
France
ALONC

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.